Additionally, the conjugation of miR-15a and miR-16-1 to ATE-RNA aptamer (APT) hybrid to target prostate-specific membrane antigen (PSMA) expressed PCa cells enhanced the strategy efficacy in vitro and in vivo by inducing the killing of cancer cells [94]. The gene discussed is FOLH1; the disease is cancer.